In NPC, METTL3-mediated m6A modification reduces ZNF750 expression, weakening its tumor-suppressor function in the ZNF750-FGF14 axis, which inhibits apoptosis and promotes NPC growth [130] (Fig. 4A and Table 1). Here, ZNF750 is linked to neoplasm.